title: [Thymic tumors].
abstract: Thymomas and thymic carcinomas are rare and slow-growing tumors, which develop within the anterior mediastinum. Thymomas are often associated with autoimmune disorders and most particularly myasthenia gravis. The treatment of choice remains a complete surgical resection. Postoperative radiotherapy is often combined in case of invasive thymoma invading into adjacent organs. Postoperative radiotherapy in stage II with invasion into capsule has been more controversial lately. In inoperable locally advanced, or metastatic thymic tumors, neoadjuvant cisplatin-based followed by surgery and radiotherapy has given interesting results in the past years.
authors.affiliation: Département de radiothérapie, institut Gustave-Roussy, 39, rue Camille-Desmoulins, 94000 Villejuif, France. lepechoux@igr.fr
authors.forename: C
authors.initials: C
authors.lastname: Le Péchoux
authors.forename: M
authors.initials: M
authors.lastname: Mahé
authors.forename: J-J
authors.initials: JJ
authors.lastname: Bretel
authors.forename: E
authors.initials: E
authors.lastname: Roberti
authors.forename: P
authors.initials: P
authors.lastname: Ruffié
mesh_terms: D002277:Carcinoma / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery*; D017024:Chemotherapy, Adjuvant; D006801:Humans; D009361:Neoplasm Invasiveness; D011379:Prognosis; D018714:Radiotherapy, Adjuvant; D013945:Thymoma / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery*; D013953:Thymus Neoplasms / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery*